Xenon Pharmaceuticals Inc.
Benzenesulfonamide compounds and their use as therapeutic agents

Last updated:

Abstract:

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.

Status:
Grant
Type:

Utility

Filling date:

28 Jul 2020

Issue date:

12 Apr 2022